Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3; BMS-986016) in combination with nivolumab in patients with melanoma who progressed during prior anti-PD-1/PD-L1 therapy Meeting Abstract
| Authors: | Ascierto, P. A.; Melero, I.; Bhatia, S.; Bono, P.; Sanborn, R. E.; Lipson, E. J.; Callahan, M. K.; Gajewski, T.; Gomez-Roca, C. A.; Hodi, F. S.; Curigliano, G.; Nyakas, M.; Preusser, M.; Koguchi, Y.; Maurer, M.; Harbison, C.; Mitra, P.; Suryawanshi, S.; Munoz-Couselo, E. |
| Abstract Title: | Initial efficacy of anti-lymphocyte activation gene-3 (anti-LAG-3; BMS-986016) in combination with nivolumab in patients with melanoma who progressed during prior anti-PD-1/PD-L1 therapy |
| Meeting Title: | COSA's 44th Annual Scientific Meeting |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 13 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2017 Nov 13-15 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-11-01 |
| Start Page: | 114 |
| Language: | English |
| ACCESSION: | WOS:000413954500144 |
| PROVIDER: | wos |
| PUBMED: | 29082610 |
| DOI: | 10.1111/ajco.12799 |
| Notes: | Meeting Abstract: 149 -- Source: Wos |
